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and vascular cell surface antigens
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Lupus autoantibodies interact directly with distinct glomerular and
vascular cell surface antigens. We have identified monoclonal anti-DNA
antibodies derived from lupus prone MRL-lpr/lpr mice that produce
glomerular immune deposits and nephritis after passive transfer to normal
mice. Particularly noteworthy is that the location of immune deposition
varied among nephritogenic Ig, and this was associated with distinctive
histologies and clinical disease profiles. Although their autoantigen bind-
ing properties differed, they were highly cross-reactive, in a manner similar
to Ig deposited in glomeruli of lupus mice. This antigen binding profile was
also typical of other previously described nephritogenic autoantibodies
that bound directly to glomerular antigens to initiate immune deposit
formation. In this study, we questioned whether ligation of different
glomerular antigens by individual autoantibodies could contribute to the
observed differences in the location of immune deposits. To examine this
possibility, monoclonal anti-DNA antibodies (IgG2a) that produced gb-
merular immune deposits in different locations were evaluated. H221
produced mesangial, intracapillary (that is, intraluminal or within the
capillary lumen) and subendothelial deposits associated with heavy pro-
teinuria, whereas H147 produced mesangial, subendothelial and linear
basement membrane deposits associated with proliferative glomerulone-
phritis. Initially, the capacity of H221 and H147 to bind directly to
gbomerular and vascular cell surfaces was evaluated. As demonstrated by
FACS, H221 bound preferentially to mesangial cells whereas H147 bound
preferentially to endothelial cells. To identify possible target cell surface
antigens, Western blots, immunoprecipitation of surface labeled cells, and
2D gel electrophoresis were employed. H221 reacted with a 108 kDa
protein on mesangial cells not identified by H147, whereas H147 reacted
with a 45 kDa protein on endothelial cells not identified by H221. These
results support the hypothesis that some nephritogenic lupus autoantibod-
ies initiate immune deposit formation through direct interaction with
glomerular antigens. Furthermore, they suggest that the site of immune
deposition is determined by both antigen binding properties of the
relevant antibody and the location of its target ligand within the gbomer-
ulus. In a given individual, therefore, the predominant autoantibody-
glomerular antigen interaction may influence the morphologic and clinical
phenotype expressed. Variation in the predominant interaction may also
contribute to variations in disease expression among individuals with lupus
nephritis.
Understanding the cellular and molecular events leading to
glomerulonephritis in systemic lupus erythematosus has been
impeded by both confusion over the properties associated with
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nephritogenic autoantibodies and lack of identification of relevant
immunoglobulins. For example, although the presence of anti-
DNA, anti-SmRNP and other autoantibodies is useful diagnosti-
cally, serum autoantibody levels do not always correlate with
disease activity [1—41. Serum autoantibody levels in patients
without clinical evidence of nephritis can be markedly elevated,
and conversely, they are occasionally undetectable in patients with
fulminant disease. Of particular relevance, there are multiple
inbred strains of mice that spontaneously develop diseases closely
resembling various aspects of human lupus [5, 6]; notably, some
strains do not develop nephritis despite elevated serum autoanti-
body levels [5—7]. Collectively these observations suggest that
there are distinguishing properties of nephritogenic Ig that enable
them to form immune deposits and initiate inflammation. In this
regard, in both human and murine lupus, we previously observed
that specific properties attributed to the antigen binding region of
nephritogenic Ig (that is, cross-reactive antigen binding proper-
ties, idiotypic relatedness) distinguished them from serum autoan-
tibodies derived from the same individuals [8—10]. Independent
observations of others support this conclusion, and this has led to
the search for specific genes that encode antibodies with patho-
genic properties [10—181.
The relevance of the antigen binding region to immune deposit
formation was further supported by passive transfer studies
involving administration of monoclonal autoantibodies to normal
mice. We and others found that only a subset of monoclonal
anti-DNA antibodies induced glomerulonephritis; not all autoan-
tibodies were nephritogenic. Of particular relevance, among
nephritogenic Ig, the phenotypic expression of disease varied with
the administered autoantibody [19, 20]. For example, monoclonal
anti-DNA antibodies were identified that produced either: gran-
ular mesangial and subendothelial immune deposits; mesangial,
intracapillary (that is, intraluminal or within the capillary lumen)
and subendothelial deposits; mesangial and linear basement
membrane, tubular and vascular deposits; and intranuclear depos-
its. Each of these patterns was associated with distinct light
microscopic appearances and different clinical features. Other
laboratories have also identified nephritogenic lupus autoantibod-
ies that produce other histologic and clinical phenotypes [21—23].
Taken together, these results suggest that the antigen binding
region of individual lupus autoantibodies influences both the
capacity of individual Ig to form immune deposits and the site of
gbomerular immune deposit formation.
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Although the pro-inflammatory properties of individual au-
toantibodies clearly contribute to the observed pathologic differ-
ences, based on the previous discussion we hypothesized: (i) the
initial event in the process, immune deposit formation, is primar-
ily influenced by the antigen binding properties of nephritogenic
Ig; and (ii) the site of immune deposit formation is determined by
the location of the target antigen within the glomerulus, through
direct interactions with pathogenic autoantibodies. Thus, varia-
tion in the location of the target glomerular antigens contributes
to the observed differences in immune deposit location.
To test this hypothesis, the capacity of two nephritogenic lupus
autoantibodies, each with distinct antigenic and pathologic prop-
erties, to hind to mesangial and endothelial cells was examined.
Following administration to normal mice, H147 produced linear
basement membrane, mesangial and subendothelial deposits as-
sociated with proliferative glomerulonephritis, whereas H221
produced mesangial, intracapillary and subendothelial deposits
associated with heavy proteinuria. Each antibody reacted with a
distinct cell surface antigen, suggesting that the observed in vivo
differences are, at least in part, due to the interaction of these
antibodies with distinct proteins on different cells within the
glomerulus.
Methods
Monoclonal antibodies (mAb)
Pertinent characteristics of the MRL-lpr/lpr-derived mAb
termed H221 and H147 have been reported previously [19, 20].
Both mAb cross reacted with multiple autoantigens; however,
their individual specificities were distinct. The pattern of glomer-
ular immune deposits produced following administration of the
relevant hybridomas to normal mice is illustrated in Figure 1; this
was associated with significant proteinuria (H147 = 1.8 0.4
mg124 hr; H221 = 3.8 1.2 mg124 hr; in our laboratory normal
mice excrete < 1 mg/24 hr, P < 0.05). An lgG anti-DNA antibody
(H73) that does not produce either glomerular immune deposits
or proteinuria (< 1 mg124 hr) after transfer to normal mice was
used for comparative purposes. Prior to use, Ig concentration and
anti-DNA activity of the purified Ig preparations and the hybrid-
oma supernatants were determined by ELISA using previously
described methods [19, 20]. The amount of Ig present in the tissue
culture supernatants ranged from 3 to 8 jg/ml.
Mesangial and endothelial cells
Mesangial cells were isolated from the glomeruli of MRL-lprllpr
mice under sterile conditions by differential sieving as previously
described [24]. Murine aortic endothelial cells were the generous
gift from Dr. Robert Auerbach, and they were maintained in
culture as described [25].
Evaluation of cell surface binding.' FACS
Cells (mesangial and endothelial) were grown in monolayers in
T-75 flasks until confluent as previously described [24]. All
subsequent steps were performed on ice. The media was aspirated
from the culture flask and replaced with an equal volume of
Hanks balanced salt solution (HBSS). A single cell suspension was
made by gently agitating the flask, without scraping. The sus-
pended cells were washed twice with HBSS, and an aliquot was
counted using a hemocytometer and trypan blue to determine cell
again with phosphate buffered saline (PBS) containing 1% bovine
serum albumin (BSA; FACS buffer), and 250,000 cells were
aliquoted to individual eppendorfs. The cells were centrifuged at
14,000 x g for one minute, the supernatants discarded, and the
cell pellets were incubated with mAb (1:1, FACS buffer: hybrid-
oma supernatant) on ice. After 45 minutes, the cells were pelleted,
washed with FACS buffer, and incubated with goat anti-mouse
IgG F(ab')2-FITC (Pel-Freez Biologicals, Rogers, AR, USA)
diluted 1:30 in PBS for 30 minutes. Following incubation, the cell
pellets were washed twice in FACS buffer and fixed with 1.0%
(wt/vol) paraformaldehyde. Cell surface binding was evaluated
with the Becton-Dickinson FACScan.
Evaluation of cell protein binding: Immunoblotting of whole
cell lysates
Cells were grown in monolayers in T-75 flasks until confluent
and washed with cold HBSS (x2). Cell lysis buffer (10 mM Trizma
base (Tris); 50 m ethylene glycol bis(b-aminoethylether)
N,N,N',N'-tetraacetic acid (EGTA); 1% (vol/vol) nonidet P-40
(NP-40); 0.4% deoxycholic acid (DOC), pH 7.4) which solubilizes
membrane proteins and lyses cells was then added to each flask to
just cover the monolayers. Single cell suspensions were prepared
by gentle agitation and scraping, and then the suspensions were
incubated in cell lysis buffer on ice. After 30 minutes, the soluble
lysates were isolated by centrifugation (14,000 X g). Total protein
concentration in the supernatants was determined using the
Biorad Protein Assay (Biorad, Hercules, CA, USA). The lysates
were then acetone precipitated, resuspended in sample buffer (1
part 20% SDS (wt/vol); I part 6.0% Tris-HCI (wt/vol), pH 6.9; 1
part 75% sucrose (wt/vol); bromophenol blue) at a concentration
of 100 jtg protein/20 il and reduced with 10 ms dithiothreitol
followed by the addition of 10 m iodoacetamide.
The samples were resolved by SDS-PAGE, using 7.5 to 13%
gradient gels as previously described [26, 27]. After electrophore-
sis for 90 minutes at 100 V the separated proteins were electro-
blotted to nitrocellulose (100 V; 1 hr). The blots were stained with
Ponceau S Red to evaluate transfer of proteins. Following block-
ing with 5% (wt/vol) dry milk (Carnation) in Western blot buffer
(WBB; 50 m'vi Tris, 200 mr't NaCl, pH 7.4) at 4°C for 16 hours, the
blots were washed in WBB and incubated at room temperature
with mAb (1:1 hybridoma supernatant: WBB; the concentration
of Ig in all supernatants was 3 to 8 g/ml) In all assays, the amount
of Ig present in the hybridoma cell culture supernatants was
relatively higher for H73 as compared to H221 or H147 (used in
near identical concentrations) when the Bradford assay was used
for quantitation (Biorad). After 1.5 hours, the blots were washed
extensively with WBB and then incubated with goat anti-mouse
IgG-horseradish peroxidase (Boehringer Mannheim Corporation,
Indianapolis, IN, USA) at a dilution of 1:1000 for an additional
one hour at room temperature. After five washes with WBB, the
bands were detected by chemiluminescence with ECL (Amer-
sham, Arlington Heights, IL, USA) according to the manufactur-
er's instructions.
Evaluation of cell surface binding: Immunoblotting of cell
surface proteins
Cells were grown in monolayer in T-75 flasks until confluent,
concentration and assess viability. The cells were then washed and all steps were performed on ice. Cell monolayers were washed
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Fig. 1. Nephritis in notmal mice after passive transfer of anti-DNA mAb H221 and H147. Light microscopy (A, C; H&E, 350X) and immunofluoresence
(B, D; direct, 300X). H221; A, B. Note the presence of capillary wall and capillary intraluminal deposits. H147; C, D. Linear basement membrane,
tubular and mesangial deposits are demonstrated. Mesangial deposits associated with mesangial expansion and interposition were demonstrated by
electron microscopy for H221 (see [20]). Subendothelial deposits were detected by electron microscopy for both of these antibodies.
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H221 Fig. 2. Cell .cu,face binding of anti-DNA mAb to
glomerular cells (FAGS). A. Mesangial cells.
B. Endothelial cells. H221 binds strongly to
both cell types but shows a preference for
mesangial cells. This conclusion was derived
from comparison of peak channel analyses of
the two antibodies and the two cell types (not
shown). H221 always bound to more mesangial
cells than endothelial cells. By contrast,
although H147 also bound to both cell types, it
i ol -i n2 1 bound to a greater number of endothelial cells.H73, a nonnephritogenic mAb, did not bind to
either cell type. Control represents unstained
mesangial or endothelial cells.
four times with HBSS, and then Sulfo-NHS-biotin (Pierce, Rock-
ford, IL, USA), 0.5 mg/mI in HBSS, was added to each monolayer.
After 20 minutes, the biotin was aspirated from the flasks, and the
cell monolayers were washed with HBSS four times and lysed in
cell lysis buffer as described above. The samples were then
preabsorbed to eliminate nonspecific binding with 5Oti protein
AJG agarose (Pierce) for one hour at 4°C. The lysates were
centrifuged at 14,000 X g for one minute, the supernatants
(soluble lysates) were removed, and they were incubated over-
night at 4°C with mAb (1:1 hybridoma supernatant: cell lysate).
The next day mAb-protein complexes were incubated with protein
A/G agarose (50 pd protein A/G per sample), for one hour at 4°C.
The samples were centrifuged (1 mm), and the supernatants were
discarded. The pellets (AJG beads containing antibody and com-
plexed biotinylated proteins) were washed twice with TENT
buffer (150 mivi NaC1, 5 mrvi EGTA, 50 mrvi Tris, 1% (vol/vol)
Triton X-100, pH 7.4) and twice with NET buffer (10 miti Tris, 2
mM EGTA, 0.1% (wt/vol) sodium docecyl sulfate (SDS), pH 7.4)
[28]. Each pellet was then resuspended in 20 j.tl sample buffer,
boiled for five minutes at 100°C and reduced as described
previously. The samples were then separated by 10% SDS-PAGE,
electroblotted and blocked with 5% milk. Immunoprecipitated
biotinylated (that is, cell surface) proteins were detected by
incubation with streptavidin-horseradish peroxidase (1:1000; Vec-
tor Laboratories, Inc., Burlingame, CA, USA) and visualization
completed using ECL as described above.
Evaluation of cell surface proteins using 2D gels
As described above, the cells were grown as monolayers until
confluent in T-25 flasks, and then they were steady-state-labeled
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Fig. 3. Reactivity of anti-DNA antibodies with cellular proteins. Western
blots of total cell lysates derived from glomerular cells. A. Mesangial cell
lysates probed with H221 and H73. B. Endothelial cell lysates probed with
H147 and H73. Numerous cell proteins are identified. Similar patterns
were observed with other murine lupus anti-DNA antibodies (not shown).
A 7.5 to 13% gradient SDS-PAGE was utilized for these experiments. HT
in panel A represents hybridoma media (see text for details).
with [35S]-methionine (0.1 mCi/mi in methionine free, serum free
media) at 37°C for 16 hours. The monolayer was then washed with
HBSS four times and surface labeled with sulfo-NHS Biotin as
described above. Cells were then solubilized and proteins were
immunoprecipitated with selected mAb as described above. After
the last wash in NET buffer, the proteins were eluted from protein
AJG as follows: 400 tl of glycine buffer [100 ma glycine, 1%
(vol/vol) Triton X-l00, pH 2.8] was then added to the immuno-
precipitate, and the samples were gently rotated for 15 minutes at
room temperature. The samples were centrifuged, and the super-
natants were transferred to a new tube. Following a second
elution of the immunoprecipitated protein with the glycine buffer,
the pH of the eluates was immediately adjusted to pH 7.0 by the
addition of 100 .tl lox PBS, 50 rl 10% BSA, 15 d 1 N sodium
hydroxide (NaOH).
The eluted proteins were precipitated by incubation overnight
at 4°C with 50 p1 of streptavidin agarose (Pierce). The samples
were centrifuged for one minute, supernatants discarded, and the
pellets were washed twice with washing buffer [100 mrvi NaH2PO4,
1% (wt/vol) Triton X-100, 0.2% (wt/vol) BSA, 0.1% (wt/vol)
sodium azide, pH 8.0] and twice with sodium phosphate buffer (10
mM NaHPO, pH 8.0). The pellets were resuspended in 20 id 2D
gel sample buffer [9.5 M urea, 2.0% (vol/vol) Triton X-100, 5.0%
(vol/vol) /3-mercaptoethanol, 2.0% (vol/vol) ampholyte (Servalyte,
Serva, Hauppauge, NY, USA)], boiled for one minute, and stored
at —70°C.
Two dimensional gel electrophoresis was performed using the
Biorad Mini-PROTEAN II 2-D Cell apparatus (Hercules, CA,
USA). After a pre-electrophoresis period of 30 minutes, proteins
were separated in the first dimension using capillary tube isoelec-
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Fig. 4. Immunoprecipitation of cell surface proteins by H221 and H147.
Western blots of immunoprecipitated biotinylated (that is, surface la-
beled) cell lysates are illustrated. A. H221 and biotinylated mesangial cell
lysates; a 108 kDa protein is identified. B. H147 and biotinylated endo-
thelial cell lysates; a group of proteins at 45 kDa is identified. Neither
monoclonal antibody immunoprecipitated a similar cell surface protein
from the alternate cell type (not shown). HT in panel B represents
hybridoma media (see text for details).
tric focusing at 750 V for three hours. The proteins were
separated in the second dimension by molecular weight using 10%
SDS-PAGE as described above. The gels were stained with
Coomassie blue, dried, and then exposed at —70°C for four weeks.
Immunoprecipitated cell surface (that is, biotinylated) proteins
were then detected by autoradiography.
Results
Nephritogenic lupus autoantibodies bind directly to mesangial and
endothelial cell surfaces
By flow cytometry, both H147 and 11221 bound to mesangial
and endothelial cell surfaces (Fig. 2). H221 bound strongly to both
cell types but showed a preference for mesangial cells (Fig. 2A).
By contrast, the binding of H147 to endothelial cells was greater
than its binding to mesangial cells (Fig. 2B). These results were
repeated at least three times for each antibody and each cell type.
Neither mesangial nor endothelial cell surface binding by H73 (an
anti-DNA antibody that does not form immune deposits) nor by
irrelevant murine Ig (not shown) was ever observed. These initial
results suggested that the antigen targets involved in the initiation
of immune deposit formation for 11221 and H147 may be differ-
ent.
Nephritogenic lupus autoantibodies with different in vivo properties
bind to different cell surface antigens
By Western blot analysis of total cell lysates of either mesangial
or endothelial cells, all of the anti-DNA antibodies evaluated
A
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By contrast, H147 immunoprecipitated a small group of surface
proteins at approximately 45 kDa from endothelial cells (Fig. 4B).
This may represent variable glycosylation products of the same
protein or different components of a single protein. These bands
were present following H147 immunoprecipitation with endothe-
hal cells on multiple occasions; however, neither these nor any
other proteins were immunoprecipitated from mesangial cells.
Furthermore, neither H73 nor H221 immunoprecipitated this or
any other endothelial cell surface protein. As illustrated, an 80
kDa protein was occasionally observed using H73 (a faint band in
this location is also seen with H147); however, this band was also
visualized using media alone (that is, HT in Figs. 3A and 4B)
without added antibody, and, therefore, it was considered to be
inconsequential.
Discussion
Fig. 5. Immunoprecipitation of cell surface proteins by H221 (2D) H221
precipitates a single species from mesangial cell surface with apI between 7.20
and 7.88.
(nephritogenic and non-nephritogenic) bound to multiple pro-
teins derived from the two cell types (Fig. 3). It was not possible
to easily distinguish unique proteins recognized by nephritogenic
or control autoantibodies. H73 bound to proteins by Western blot
but not to cell surface by FACS, indicating that the proteins
recognized were intracellular. These observations confirm the
cross-reactive properties of lupus autoantibodies, however it also
illustrates the difficulties using total cell lysates to evaluate cell
surface protein binding by lupus autoantibodies. This problem
was resolved by labeling cell surface proteins with biotin prior to
immunoprecipitation with each mAb. With this technique, immu-
noreactive cell surface proteins were identified with H221 and
H147, whereas neither H73 nor normal Ig reacted with cell
surface proteins.
The interactive proteins identified by H221 and H147 were
distinct. As illustrated in Figure 4A, following biotinylation of
mesangial cell surface proteins, H221 reacted with a 108 kD
protein. Using 2D gel electrophoresis, this protein appeared as a
single band with a p1 between 7.20 to 7.88 (Fig. 5). A protein of
this size and charge was never identified by either H147 or the
non-nephritogenic Ig, H73. This protein was never immunopre-
cipitated using endothelial cells, H221 and identical procedures.
This is the first demonstration that individual, nephritogenic
anti-DNA antibodies that produce different morphologic and
clinical patterns of disease after passive transfer to normal mice,
interact with distinct cell surface proteins in the formation of
glomerular immune deposits. H147, which produced mesangial,
subendothelial and linear basement membrane deposits, bound
preferentially to endothelial cell surfaces and immunoprecipitated
a 45 kDa endothelial cell surface protein(s), whereas H221, which
produced mesangial, intracapillary and subendothelial deposits
bound preferentially to mesangial cell surfaces and immunopre-
cipitated a 108 kDa mesangial cell surface protein. H147 did not
immunoprecipitate mesangial cell surface proteins, and H221 did
not immunoprecipitate endothelial cell surface proteins. The
specificity of these interactions was further supported by the lack
of reactivity of non-nephritogenic anti-DNA antibodies with
either cell type. Isolation and identification of these cell surface
proteins is in progress. Preliminary amino acid analysis suggests
the presence of a single but distinct protein from each cell type
(unpublished data), further supporting the specificity of these
interactions.
The promiscuous behavior of both human and murine lupus
autoantibodies is now well appreciated [29—321. We and others
have reported cross-reactivity of anti-DNA and other autoanti-
bodies and this characteristic distinguishes lupus autoantibodies
from their natural counterparts in normal serum [8, 9, 151. This
feature is particularly apparent among nephritogenic Ig [16, 18,
33]. Moreover, we and others have described anti-DNA antibod-
ies that cross react with glomerular antigens to initiate immune
deposit formation [20, 27, 34—36]. The novel aspect of the present
study is the observation that pathogenic lupus autoantibodies
form immune deposits at different locations within the glomerulus
through direct interactions with distinct glomerular cell surface
antigens. Thus, the location of immune deposition appears to be
influenced by both the antigen binding properties of the patho-
genic Ig as well as the location of the target glomerular antigen. In
this regard, structural considerations applied to explain disease
relevant cross-reactivity of pathogenic lupus autoantibodies also
apply to target antigens. In the glomerular microenvironment,
therefore, the relevant antigen may not distinguish between its
natural higand and an interactive autoantibody.
Although the results suggest that interaction of these nephrito-
genie autoantibodies with individual cell surface antigens contrib-
ute to their different in vivo behavior, they do not exclude the
possibility that more than one interaction per antibody may be
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operative in the formation of immune deposits. Accordingly, both
H221 and H147 produced deposits at multiple glomerular loca-
tions. They also cross reacted with multiple autoantigens, includ-
ing both intracellular (that is, ssDNA, dsDNA, 5mRNP) and
basement membrane constituents (that is, heparan sulfate, lami-
nm). These types of interactions may have contributed to local
immune complex formation in vivo, by either in situ complex
formation of autoantibodies with circulating autoantigens with
affinity for glomeruli or direct binding of autoantibodies with
other endogenous glomerular antigens. Regarding the former
possibility, Termaat et al have provided evidence to support local
formation of autoantibody-nucleosome complexes in vivo; here
the antigen (nucleosome) may determine the location of immune
deposition by binding to specific glomerular sites [37, 38]. In
support of the latter hypothesis, we observed that H147 also reacts
with collagen IV (Vargas, Kalluri and Madaio, unpublished
observation). This type interaction (H147-collagen IV) may have
been responsible for the linear basement membrane deposits that
were present in over half of the mice that received H147 [20, 271.
Numerous reports of cross-reactivities of anti-DNA autoantibod-
ies with phospholipids, cell surface antigens and basement mem-
brane antigens provide additional support for this possibility. In
any case, our results support the notion that the antigen binding
specificity of the pathogenic autoantibody, along with the site of
target antigen, influence the location of immune deposit forma-
tion.
These observations have at least tvo disease-related implica-
tions. Extrapolating from other models of experimentally induced
nephritis, it is evident that the location of immune deposit
formation influences the recruitment of inflammatory mediators,
the local cellular response and the ultimate pathologic and clinical
expression of disease [39]. Thus, in an individual with lupus
nephritis, the predominant autoantibody-glomerular antigen in-
teraction(s) are likely to determine the clinical and histologic
expression and course of nephritis. This phenomenon could also
contribute to the diverse histologic and clinical presentations
commonly observed among different individuals, with different
glomerular antigen-antibody interactions predominating and de-
termining the clinical phenotype.
Furthermore, ligation of glomerular antigens by autoantibod-
ies, per Se, may have direct effects on the local inflammatory
response through receptor-ligand-like interactions. The clinical
manifestations of these effects could be influenced by the func-
tional properties of the interactive antigen (that is, receptor).
Support for this hypothesis is provided by recent observations of
experimentally induced glomerulonephritis, where glomerular
antigens involved in the initiation of immune deposit formation
have been identified. In many cases, the relevant ligands were
found to be either receptors or demonstrate remarkable homol-
ogy with previously characterized receptors [39—41]. The func-
tional and pathologic consequences of these types of interactions
may be significant, leading to direct perturbation of cellular
activity in addition to inflammation. In this regard, although
intensive research has been devoted to understanding the cascade
of inflammatory/fibrogenic mediators and secondary events initi-
ated by immune complex formation [39], consideration of the
consequences of autoantibody ligation within the local milieu per
se has been relatively neglected. These receptor-like interactions
could have profound effects, influencing cell-cell and cell-matrix
interactions, cell signaling events and receptor mediated pro-
cesses, ultimately leading to alterations in the inflammatory!
fibrogenic response.
Studies of experimentally induced antibodies directed at either
renal or non-renal antigens support this notion. Autoantibodies
have been observed to bind to cell surface receptors, competitively
inhibit the binding of natural ligands, possess agonistic activity
and, in some cases, modulate disease activity [42—461. An example
relevant to lupus is provided by our recent observation that some
anti-DNA antibodies have the capacity to bind to both DNA and
its natural ligand DNase I [47]. Of particular relevance, a subset of
these anti-DNAIDNase antibodies bind to a cyclic peptide corre-
sponding to the active site of DNase and inhibit the functional
activity of the enzyme. In addition to the potential immunomodu-
lating effects of this type of interaction, it suggests that lupus
autoantibodies can interfere with the functional activity of normal
proteins. In the context of ongoing disease at the site of immune
deposit formation, therefore, these types of interactions (that is,
interference with either enzymatic activity or cell-cell interac-
tions) have the potential to modulate ongoing inflammatory!
fibrogenic responses in vivo. Thus, the ultimate phenotypic ex-
pression of disease may be dependent on both the location and
the nature!function of the target antigen. By further examination
of these types of interactions, such as those occurring between
H221 and H147 and their corresponding glomerular ligands, we
believe that additional information related to pathogenesis and
progression of nephritis will be derived. In particular, more
precise identification of the relevant glomerular antigens involved
in lupus nephritis should provide pivotal information relevant to
understanding local phenomenon that contribute to disease activ-
ity. Furthermore, elucidation of the structural basis of pathoge-
netically relevant autoantigen-autoantibody interactions should
also provide the basis for rational design of specific modulators of
these events.
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